Clinical Trials Logo

Clinical Trial Summary

This study aims to evaluate more objectively, through an imaging technique such as ultrasound, changes in joints and entheses of patients with active psoriatic arthritis (PAs) who will start treatment with Apremilast after the failure of other therapies such as synthetic DMARD (metrotrexato , Leflunomide ...).

The hypothesis of the study is that the technique of ultrasound can demonstrate the efficacy of Apremilast in the treatment of patients with active PAs


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT03191539
Study type Interventional
Source Hospital Universitari Vall d'Hebron Research Institute
Contact Juan José de Agustín de Oro, MD
Phone 93 489 30 00
Email jjdagust@vhebron.net
Status Not yet recruiting
Phase Phase 3
Start date November 2, 2017
Completion date June 14, 2019